The expression pattern of immunohistochemical P16-/Rb+ has been reported in large cell neuroendocrine carcinoma of the lung and Merkel cell carcinoma of the skin to be associated with treatment and prognosis; however, no literature has been reported on g-NETs (20–22). Here, CDKN2A is linked to large cell neuroendocrine carcinoma.